Papers

2

Total Citations

75

H-Index

2

About

Sunil K. Mallanna is a pioneering researcher in stem cell biomanufacturing, with a primary focus on developing scalable, automated platforms for the production and differentiation of human pluripotent stem cells (hPSCs). His major contribution lies in addressing a critical bottleneck in regenerative medicine: the transition from labor-intensive, variable manual cell culture to robust, high-throughput robotic systems. Mallanna’s work demonstrates that automated biomanufacturing can reliably maintain hiPSC self-renewal and guide their functional differentiation, a breakthrough that promises to accelerate clinical translation and drug screening. His most cited paper (2021, 68 citations) provides a foundational framework for this approach, while a related 2020 study (7 citations) further refines the methodology. By integrating robotics with stem cell biology, Mallanna has helped pave the way for reproducible, large-scale production of cells for therapy. His achievements are particularly notable for bridging engineering and biology, offering a practical solution to one of the field’s most persistent challenges. For students and researchers, his work exemplifies how interdisciplinary innovation can transform a promising technology into a scalable reality.

Research Focus

Key Achievements

2
H-Index
2
Papers
75
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells
68 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: National Center for Advancing Translational Sciences, National Institutes of Health

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago